Multidimensional geriatric evaluation in elderly cancer patients: A practical approach

European Journal of Cancer Care

Volumn 13, Issue 5, 2004, Pages 424-433

  Basso, U ^a   Monfardini, S ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Chemotherapy; Comorbidity; Elderly; Geriatric assessment; Informed consent

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CAMPTOTHECIN; CAPECITABINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOCHROME P450 INHIBITOR; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

AGED; CANCER; CARDIOTOXICITY; CHEMOTHERAPY; COGNITION; COMORBIDITY; DECISION MAKING; DOSE RESPONSE; DRUG TRANSPORT; ELDERLY CARE; GERIATRICS; HEALTH CARE; HUMAN; INFORMED CONSENT; MALNUTRITION; MEDICAL RESEARCH; REVIEW; SIDE EFFECT; SOCIAL ASPECT;

AGED; COMORBIDITY; GERIATRIC ASSESSMENT; HEALTH STATUS; HUMANS; NEOPLASMS; PATIENT CARE TEAM; TREATMENT OUTCOME;

EID: 11444251626     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2004.00551.x     Document Type: Review

References (55)

1. Balducci L., Extermann M. & Carreca I. (2001) Management of breast cancer in the older woman. Cancer Control 8, 431-441.
2. Balducci L. & Yates J. (2000) General guidelines for the management of older patients with cancer. Oncology (Huntingt) 14, 221-227.
3. Ball K., Berch D.B., Helmers K.F., Jopbe J.B., Leveck M.D., Marsiske M., Morris J.N., Rebok G.W., Smith D.M., Tennstedt S.L., Unverzagt F.W. & Willis S.L. (2002) Effects of cognitive training interventions with older adults. A randomized controlled trial. Journal of the American Medical Association 288, 2271-2281.
4. Basso U., Shams M., Pogliani C., Rossi E., Brunello A., Serraino D. & Monfardini S. (2003) Factors influencing the obtainment of written informed consent for chemotherapy administration in elderly cancer patients. 8th International Conference on Geriatric Oncology, Rome 21-22 November 2003, Abstract 21.
5. Bernardi D., Milan I., Balzarotti M., Spina M., Santoro A. & Tirelli U. (2003) Comprehensive geriatric evaluation in elderly patients with lymphoma: feasibility of a patient tailored treatment plan. Journal of Clinical Oncology 21, 754-757.
6. Biganzoli L., Goldhirsch A., Straehle C., Castiglione-Gertsch M., Therasse P., Aapro M., Minisini A. & Piccarti M.J. (2004) Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG). Annals of Oncology 15, 210-210.
7. Bravo G. & Herbert R. (1997) Age- and education-specific reference values for the mini-mental and modified mini-mental state examinations derived from a non-demented elderly population. Geriatric Psychiatry 12, 1008-1018.
8. Bremnes R.M., Andersen K. & Wisten E.A. (1995) Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. European Journal of Cancer 31A, 1995-1999.
9. Charlson M.E., Pompei P., Ales K. & MacKenzie C.R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40, 373-383.
10. Crivellari D., Bonetti M., Castiglione-Gertsch M., Gelber R.D., Rudenstam C.M., Thurlimann B., Price K.N., Coates A.S., Hurny C., Bernhard J., Lindtner J., Collins J, Senn H.J., Cavalli F., Forbes J., Gudgeon A., Simoncini E., Cortes-Funes H., Veronesi A., Fey M. & Goldhirsch A. (2000) Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. Journal of Clinical Oncology 18, 1412-1422.
11. Davis T.C., Williams M.V., Marin E., Parker R.M. & Glass J. (2002) Health literacy and cancer communication. CA: A Cancer Journal for Clinicians 52, 134-149.
12. Delafuente J.C. (2003) Understanding and preventing drug interactions in elderly patients. Critical Reviews in Oncology and Hematology 48, 133-143.
13. Extermann M. (2000) Measuring comorbidity in older cancer patients. European Journal of Cancer 36, 453-471.
14. Extermann M. (2003) Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control 10, 463-468.
15. Extermann M., Albrand G., Chen H., Zanetta S., Schonwetter R., Zulian G.B., Cantor A. & Droz J.P. (2003) Are older French patients as willing as older American patients to undertake chemotherapy? Journal of Clinical Oncology 21, 3214-3219.
16. Extermann M., Overcash J., Lyman G.H., Parr J. & Balducci L. (1998) Comorbidity and functional status are independent in older cancer patients. Journal of Clinical Oncology 16, 1582-1587.
17. Folstein M.F., Folstein S.E. & McMugh P.R. (1975) 'Mini mental state': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
18. Franceschi S. & La Vecchia C. (2001) Cancer epidemiology in the elderly. Critical Reviews in Oncology and Hematology 39, 219-226.
19. Giovinazzi Bannon S., Rademaker A., Lai G. & Benson A.B. (1994) Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center Study. Journal of Clinical Oncology 12, 2447-2452.
20. Guizot Y., Vellas B. & Garry P.J. (1996) Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation. Nutrition Reviews 54, S59-S65.
21. Gurney H. (1996) Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. Journal of Clinical Oncology 14, 2590-2611.
22. Hamilton M. (1968) Development of a rating scale for primary depressive illness. British Journal of Society of Clinical Psychology 6, 278-296.
23. Hickie C. & Snowdon J. (1987) Depression scales for the elderly: GDS. Clinical Gerontology 6, 51-53.
24. Hutchins L.F., Unger J.M., Crowley J.J., Coltman C.A. & Albain K.S. (1999) Under-representation of patients 65 years of age or older in cancer-treatment trials. New England Journal of Medicine 341, 2061-2067.
25. John V., Mashru S. & Lichtman S. (2003) Pharmacological factors influencing anticancer drug selection in the elderly. Drugs Aging 20, 737-759.
26. Katz S., Ford A.B., Moskowitz R.W., Jackson B.A. & Jaffe M.W. (1963) Studies of illness in the age. The index of ADL: a standardised measure of biological and psychological function. Journal of the American Medical Association 185, 914-919.
27. Kemeny M.M., Peterson B.L., Kornblith A.B., Muss H.B., Wheeler J., Levine E., Bartlett N., Fleming G. & Cohen H.J. (2003) Barriers to clinical trial participation by older women with breast cancer. Journal of Clinical Oncology 21, 2268-2275.
28. Lawton M.P. & Brody E.M. (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186.
29. Levi F., Lucchini F., Negri E., Boyle P. & La Vecchia C. (2001) Changed trends of cancer mortality in the elderly. Annals of Oncology 12, 1467-1477.
30. Lewis J.H., Meredith L.K., Goldman D.P., Trimble E.L., Kaplan R., Montello M.J., Housman M.G. & Escarce J.J. (2003) Participation of patients 65 years of age or older in cancer clinical trials. Journal of Clinical Oncology 21, 1383-1389.
31. Linn B.S., Linn M.W. & Gurel L. (1968) Cumulative Illness Rating Scale. Journal of the American Geriatrics Society 16, 622-626.
32. Liu H.C., Teng E.L., Lin K.N., Hsu T.C., Guo N.W., Chou P., Hu H.H., Cheng W.N. & Chiang B.N. (1994) Performance on a dementia screening test in relation to demographic variables. Study of 5297 community residents in Taiwan. Archives of Neurology 51, 910-915.
33. Mandelblatt J.S., Edge S.B., Meropol N.J., Senie R., Tsangaris T., Grey L., Peterson B.M. Jr, Hwang Y.T., Kerner J. & Weeks J. (2003) Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. Journal of Clinical Oncology 21, 855-863.
34. Miller M.D., Paradis C.F., Houck P.R., Mazumdar S., Stack J.A., Rifai A.H., Mulsant B. & Reynolds C.F. 3rd (1992) Rating chronic medical illness burden in gero-psychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Research 41, 237-248.
35. Monfardini S. (2002) Prescribing anti-cancer drugs in elderly cancer patients. European Journal of Cancer 38, 2341-2346.
36. Monfardini S., Crivellari G., Zoli V., Salvagno L., Bordonaro R., Vivaldi A., Benevolo G., Fratino L., Majolino V., Chiarion-Sileni V., Bianco A., Tomassi O. & Aversa S.M.L. (2002) Vinorelbine (VNR) and prednisone (PDN) in elderly (70 years) frail patients (pts) with non-Hodgkin's lymphomas (NHL). A phase II study of Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG). Proceedings of the American Society of Clinical Oncology 21, 204b.
37. Monfardini S., Ferrucci L., Fratino L., del Lungo I., Serraino D. & Zagonel V. (1996) Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 77, 395-401.
38. Monfardini S. & Perrone F. (1997) Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (≥ 70 years of age)? Arbiter. European Journal of Cancer 33, 1723-1724.
39. Newell S., Sanson Fisher R.W., Girgis A. & Bonaventura A. (1998) How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems. Data from a survey of five oncologists. Cancer 83, 1640-1651.
40. Pfeiffer E. (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatrics Society 23, 433-441.
41. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., Parodi S., Dal Lago D., Gioia F., Monfardini S., Aapro M.S., Serraino D. & Zagonel V. (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. Journal of Clinical Oncology 20, 404-502.
42. Reuben D.B. & Siu A.L. (1990) An objective measure of physical function of elderly out-patients. The physical performance test. Journal of the American Geriatrics Society 38, 1105-1112.
43. Rockwood K., Stadnyck K., MacKnight C., McDowell I., Hebert R. & Hogan D.B. (1999) A brief clinical instrument to classify frailty in elderly people. Lancet 353, 205-206.
44. Satariano W.A. (1992) Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. Journal of Gerontology 47, 24-31.
45. Satariano W.A. & Silliman R.A. (2003) Comorbidity: implications for research and practice in geriatric oncology. Critical Reviews in Oncology and Hematology 48, 239-248.
46. Scott P.A., Valimaki M., Leino-Kilpi H., Dassen T., Gasull M., Lemonidou C. & Arndt M. (2003) Autonomy, privacy and informed consent 3: elderly care perspective. British Journal of Nursing 12, 158-168.
47. Slaviero K.A., Read J.A., Clarke S.J. & Rivory L.P. (2003) Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutrition and Cancer 46, 148-157.
48. Terret C. (2004) Management and geriatric assessment in the elderly. Experimental Review of Anticancer Therapy 4, 469-475.
49. Tranchand B., Laporte S., Glehen O. & Freyer G. (2003) Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly. Critical Reviews in Oncology and Hematology 48, 199-214.
50. Wildiers H., Highley M.S., de Bruijn E.A. & van Osterom A.T. (2003) Pharmacology of anticancer drugs in the elderly population. Clinical Pharmacokinetics 42, 1213-1242.
51. Wymenga A.N.M., Slaets J.P.J. & Sleijfer D.T. (2001) Treatment of cancer in old age, shortcomings and challenges. The Netherlands Journal of Medicine 59, 259-266.
52. Yancik R. (1997) Cancer burden in the aged; an epidemiologic and demographic overview. Cancer 80, 1273-1283.
53. Yancik R., Wesley M.N., Ries L.A.G., Havlik R.J., Edwards B.K. & Yates J.W. (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. Journal of the American Medical Association 285, 885-892.
54. Yee K.W., Pater J.L., Pho L., Zee B. & Siu L.L. (2003) Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? Journal of Clinical Oncology 21, 1618-1623.
55. Zagonel V., Fratino L., Piselli P., Zagonel V., Fratino L., Piselli P., Milan I., La Conca G., Serraino D. & Monfardini S. (2002) The comprehensive geriatric assessment (CGA) predicts mortality among elderly cancer patients (ECP). Proceedings of the American Society of Clinical Oncology 21, 365a.